LTH-A Activators
Heat-labile enterotoxins, particularly from E. coli, primarily function by perturbing the adenylate cyclase-cAMP pathway in host cells. This perturbation leads to the hallmark symptom of diarrhea. Activators of LTH-A, as tabulated above, revolve around the modulation of the cAMP pathway, either through direct elevation of cAMP or through cellular mechanisms that lead to its increase. Exogenous application of these chemicals can act in tandem with LTH-A to accentuate the cellular responses tied to cAMP elevation.
From another perspective, the rationale behind using such activators is to mimic, potentiate, or amplify the inherent activity of LTH-A. By enhancing the cellular responses associated with LTH-A, these activators play a pivotal role in driving the biological effects downstream of cAMP elevation. Such combined effects might have implications in understanding the full of LTH-A as a toxin, especially in contexts where LTH is being considered for transcutaneous delivery of antigens. This reinforces the importance of precisely understanding the interplay between LTH-A and its activators.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine can upregulate adenylate cyclase, potentially enhancing the cAMP increase caused by LTH-A. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
PGE2 is known to enhance cAMP production. In the context of LTH-A activity, this can act to potentially amplify the cAMP-mediated cellular effects. | ||||||
Calcium dibutyryladenosine cyclophosphate | 362-74-3 | sc-482205 | 25 mg | $147.00 | ||
A cell-permeable analog of cAMP that can enhance cellular responses linked to increased cAMP levels, such as those promoted by LTH-A. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Directly stimulates adenylate cyclase, amplifying the cAMP response that LTH-A would induce. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
A non-selective inhibitor of phosphodiesterases, leading to increased cAMP levels. This can enhance responses tied to LTH-A activity. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Phosphodiesterase inhibitor that raises cAMP levels, potentially amplifying the cellular effects initiated by LTH-A. | ||||||
Zardaverine | 101975-10-4 | sc-201208 sc-201208A | 5 mg 25 mg | $88.00 $379.00 | 1 | |
Another phosphodiesterase inhibitor, leading to elevated cAMP levels which could accentuate LTH-A related cellular activities. | ||||||
Adenosine | 58-61-7 | sc-291838 sc-291838A sc-291838B sc-291838C sc-291838D sc-291838E sc-291838F | 1 g 5 g 100 g 250 g 1 kg 5 kg 10 kg | $34.00 $48.00 $300.00 $572.00 $1040.00 $2601.00 $4682.00 | 1 | |
Through certain receptors, adenosine can lead to increased cAMP levels, thus potentially enhancing the cellular effects tied to LTH-A activity. | ||||||
SQ 22536 | 17318-31-9 | sc-201572 sc-201572A | 5 mg 25 mg | $95.00 $363.00 | 13 | |
An adenylate cyclase inhibitor that in specific contexts might lead to compensatory mechanisms that amplify cAMP production. | ||||||